Summary of Key Points Core Viewpoint - As of June 22, 2025, 14 A-share listed companies have released their mid-year profit forecasts, indicating a mixed performance with 9 companies expecting profit increases and 5 anticipating declines [1][3]. Group 1: Profit Forecasts - Saint Nor Biotechnology expects a net profit of 77.03 million to 94.14 million yuan, with a year-on-year growth of 253.54% to 332.10%, driven by strong performance in its peptide raw material business [2][3]. - Luxshare Precision anticipates a net profit of 6.475 billion to 6.745 billion yuan, reflecting a growth of 20% to 25%, despite challenges from global trade dynamics [3]. - 13 out of the 14 companies forecast profits, while only one company, Ningbo Huaxiang, expects a loss [3][4]. Group 2: Loss Forecasts - Ningbo Huaxiang predicts a loss of 273.9 million to 369.9 million yuan, a decline of 151.09% to 169.12%, primarily due to a one-time impact from the divestment of its European business [4]. - Zhongce Rubber expects a net profit of 1.91 billion to 2.2 billion yuan, with a decrease of 13.38% to 24.79%, attributed to rising raw material costs and external sales challenges [4]. Group 3: Revenue Growth - Ying Shi Innovation, a newly listed company, forecasts a revenue growth of 32.38% to 57.1%, with a net profit increase of -4.65% to 12.49% [4].